ALM-488-003
Enrolling By Invitation
99 years and younger
All
Phase
N/A
1 Location
Brief description of study
This study is a prospective, open-label, multicenter clinical trial to evaluate the usability of the
REVEALTM 475 system in patients treated with bevonescein for nerve visualization during
surgery. The purpose is to characterize the feasibility of using the REVEALTM 475 by obtaining surgeon perspective on 1. Illumination and 2. Ease of use
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Updated on
01 Aug 2024.
Study ID: 854520
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
